Pacific Biosciences of California PACB Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$546.38M-75.0% | -$312.22M-1.8% | -$306.74M+2.4% | -$314.25M-73.4% | ||
| $12.99M-5.7% | $13.77M+20.2% | $11.46M+20.9% | $9.48M+31.7% | ||
| $41.67M-41.3% | $71.04M-1.5% | $72.12M-8.3% | $78.61M+7.2% | ||
| —— | -$205K— | —— | —— | ||
| $15M— | —— | $0— | $0— | ||
| —— | —— | —— | -$5.46M-176% | ||
| —— | —— | —— | $33.91M+159% | ||
| $2.48M— | —— | —— | —— | ||
| $3.16M— | —— | $13.1M— | —— | ||
| -$8.51M— | —— | $9.79M-25.7% | $13.17M— | ||
| —— | —— | $2.45M+176% | $887K— | ||
| -$1.69M-369% | $628K-40.7% | $1.06M+15.4% | $918K+54.8% | ||
| —— | -$2.11M+79.8% | -$10.42M-179% | -$3.73M— | ||
| $369.45M+1,248% | $27.41M+232% | $8.26M+805% | $913K+128% | ||
| $3.98M-67.3% | $12.17M+78.6% | $6.81M-1.7% | $6.93M-5.1% | ||
| $723K+106% | -$11.92M-36.1% | -$8.76M-13.4% | -$7.72M— | ||
| -$18.7M-2,100% | -$850K-106% | $15.06M+534% | $2.38M+108% | ||
| -$111.21M+46.0% | -$206.06M+20.5% | -$259.17M+1.5% | -$263.21M-137% | ||
| $2.8M— | —— | $8.84M-47.2% | $16.75M+182% | ||
| $216.91M-56.5% | $498.64M-34.1% | $756.57M+70.9% | $442.79M-55.2% | ||
| $0— | —— | —— | $0-100% | ||
| —— | —— | —— | —— | ||
| —— | $0— | $0-100% | $179K— | ||
| $115.45M-6.9% | $124M— | —— | $116.08M+116% | ||
| $0— | $0— | —— | $0-100% | ||
| —— | -$42.99M— | —— | $9.62M-99.2% | ||
| $7.67M— | —— | -$145.68M— | —— | ||
| $8.26M-44.2% | $14.81M-5.6% | $15.69M+11.7% | $14.05M+103% | ||
| $369.45M+1,248% | $27.41M+232% | $8.26M+805% | $913K+128% | ||
| -$18.7M-2,100% | -$850K-106% | $15.06M+534% | $2.38M+108% | ||
| $12.99M-5.7% | $13.77M+20.2% | $11.46M+20.9% | $9.48M+31.7% | ||
| —— | —— | —— | —— | ||
| $0-100% | $154.41M— | $0— | $0— | ||
| $723K+106% | -$11.92M-36.1% | -$8.76M-13.4% | -$7.72M— | ||
| -$8.51M— | —— | $9.79M-25.7% | $13.17M— | ||
| $9.77M+102% | $4.83M-54.4% | $10.58M+75.6% | $6.03M+789% | ||
| $4.37M-66.5% | $13.04M+1.6% | $12.84M+5,162% | $244K+106% | ||
| $3.98M-67.3% | $12.17M+78.6% | $6.81M-1.7% | $6.93M— | ||
| -$1.69M-369% | $628K+159% | -$1.06M— | —— | ||
| —— | —— | —— | —— | ||
| —— | $0— | $0-100% | $179K— | ||
| $340.07M-42.7% | $593.97M-22.8% | $769.52M+33.6% | $575.8M+36.3% | ||
| —— | —— | —— | —— | ||
| $0-100% | $50.2M— | $0— | $0— | ||
| —— | —— | $15.32M+36.4% | $11.23M— | ||
| —— | -$2.11M+79.8% | -$10.42M-179% | -$3.73M— | ||
| $723K+106% | -$11.92M-36.1% | -$8.76M-13.4% | -$7.72M— | ||
| $0— | $0-100% | $441M— | $0— | ||
| —— | —— | —— | —— | ||
| -$113.92M+46.3% | -$212.25M+20.8% | -$268.02M+4.3% | -$279.96M-139% | ||
| -$113.92M+46.3% | -$212.25M+20.8% | -$268.02M+4.3% | -$279.96M-139% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pacific Biosciences of California generate?
- Pacific Biosciences of California (PACB) generated -$111.8M in operating cash flow over the trailing twelve months.
- What is Pacific Biosciences of California's free cash flow?
- After $4.5M of capital expenditures, Pacific Biosciences of California's free cash flow was -$116.2M over the trailing twelve months, up 34.8% year over year.
- Where does Pacific Biosciences of California's cash flow data come from?
- Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
